MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    DPPX Autoimmune Encephalitis Associated with Severe Multifocal Dystonia.

    E. Roddy, E. Gentry, P. Hedera, V. Holiday, D. Robertson (LOUISVILLE, USA)

    Objective: To describe a novel motor phenomenology in an individual diagnosed with anti-DPPX encephalitis at our institution and to compare it with previously known phenotypic…
  • 2024 International Congress

    Therapeutic challenges of long-standing chelator therapy in Wilson’s Disease

    C. Guedes Vaz, H. Pessegueiro, J. Castro Ferreira, J. Gandara, V. Dionísio Lopes, E. Silva, S. Ferreira, C. Pereira, D. Valadares, L. Maia, J. Presa, A. Pinto, A. Costa, C. Rolanda, C. Agostinho, I. Gonçalves, P. Peixoto, R. Costa, S. Lopes, M. Magalhães (Porto, Portugal)

    Objective: To determine the frequency of side effects of long-term copper chelation therapy in Wilson’s disease (WD). Background: WD is a neurometabolic autosomal recessive disorder…
  • 2024 International Congress

    Movement-Related Potentials Recorded Using Cerebellar Deep Brain Stimulation Leads

    U. Saha, T. Grippe, Y. Lin, M. Callister, G. Sorrento, J. Nankoo, R. Munhoz, A. Fasano, S. Kalia, R. Chen (Toronto, Canada)

    Objective: Investigate cerebellar local field potentials (LFPs) associated with movement using DBS leads in patients with spinocerebellar ataxia. Background: The Bereitschaftspotential (BP) detectable via EEG…
  • 2024 International Congress

    Altered levels of interleukin-6 in Parkinson’s disease patients with and without Covid-19

    R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in Parkinson's disease (PD) patients with and without Сovid-19. Background: Scientists say that the infectious agent SARS-CoV-2 increases the…
  • 2024 International Congress

    Case Studies of Real-World Brain Sensing Showing Patient-Specific Trends to Inform Therapy Management in Parkinson’s Disease

    A. Nourmohammadi, E. Fehrmann, A. Holt-Becker, R. Raike (New Brighton, USA)

    Objective: Explore the utility of chronic brain sensing in identifying patient-specific trends that could be useful to tailor deep brain stimulation (DBS) in Parkinson’s disease…
  • 2024 International Congress

    Exploring the Therapeutic Potential of Microglial Modulation in Parkinson’s Disease: A Study on Structural Synaptic Plasticity

    F. Fares Taie, I. Taravini, L. Rela (Buenos Aires, Argentina)

    Objective: We aim to explore the role of glial cells in Parkinson's disease and assess whether modulating microgliafunction could offer therapeutic benefits. Specifically, we investigate…
  • 2024 International Congress

    Eye Blink Rate and Putamen DaTScan Covariation in Parkinson’s Disease

    Q. Salardaine, V. Vasudevan, N. Villain, E. Biondetti, S. Lehéricy, M. Vidailhet, P. Pouget (Paris, France)

    Objective: To examine the relationship between blink rate and DaTScan in Parkinson’s disease. Background: Spontaneous eye-blink rate (BR) is blinking without external triggers. Parkinson's disease…
  • 2024 International Congress

    Genetic Variants and Levodopa Response in Parkinson’s Disease: Insights from MAO-B and DAT1 Polymorphisms

    S. Sarkar, A. Biswas, S. Ansari, S. Sengupta, S. Choudhury, R. Banerjee, S. Chatterjee, S. Dey, H. Kumar (Kolkata, India)

    Objective: This study aimed to find the association of genetic variations between Parkinson’s disease (PD) patients with and without levodopa-induced dyskinesia (LID). we intended to…
  • 2024 International Congress

    Decline in functionality according to WHODAS 2.0 associated with disease progression in people with Parkinson’s disease

    N. Pereira, K. Nóbrega, I. Nascimento, L. Matos, L. Aranha, C. de Paula, C. Santana, R. Bocicovar, G. Campos, F. Fidelis, G. Dos Santos, I. Barone, V. Ponciano, M. Piemonte (São Paulo, Brazil)

    Objective: To investigate the decline in functionality according to WHODAS-2.0 from early to intermediate stages of PD. Background: Parkinson's disease (PD) is an incurable and…
  • 2024 International Congress

    Lessons from the COVID-19 Lockdown: A Novel Mentorship Program for Young Neurosurgeons, Neurologists and Medical Students

    M. Elsayed, A. Motawei, A. Abdelrahman, A. Elgohary, B. Lashin, F. Monib, A. Abdelaal, E. Abdelazim, H. Basem (Mansoura, Egypt)

    Objective: To propose novel virtual mentorship program as a teaching tool to improve career skills among young Neurosurgeon and Ophthalmologists. Background: COVID‐19 pandemic has caused…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley